A device that analyzes blood levels of prostate-specific antigen (PSA) is one of the first doctor’s-office uses of microfluidics–technology that can manipulate fluids on a chip at microscopic scales. When a cartridge bearing a blood sample is inserted into the tabletop device, an accurate reading can be completed in 15 minutes, helping monitor the health of patients with prostate cancer. The procedure used now involves sending a sample to a lab for analysis, which often takes a day or two. The device received European approval in June.
Credit: Christopher Harting
Product: Claros DX 1
Cost: To be announced in late 2010
Availability: Late 2010 in selected European markets
Other products in this section:
Subscribe to Continue Reading
Uh oh–you've read all of your free articles for this month.
Deep Learning Is a Black Box, but Health Care Won’t Mind
New algorithms are able to diagnose disease as accurately as expert physicians.
Smartphone-Controlled Cells Could Pump Insulin for Diabetics
Researchers used optogenetics and a mobile app to stimulate cells that were designed to produce insulin in diabetic mice.
Animals Set Survival Record Inside Artificial Womb
Fetal lambs lived for weeks in a fluid-filled bag. Tests to help premature babies could begin in three years.